ClinicalTrials.Veeva

Menu

Intravenous Iron May Increase Depression Among Hemodialysis Patients

B

Benha University

Status

Completed

Conditions

Iron Deficiency Anemia
Hemodialysis Complication
Depression

Treatments

Other: Intravenous iron therapy

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT03157050
BN-13058

Details and patient eligibility

About

the aim of this study is to assess whether increased ferritin after intravenous iron therapy will lead to increased prevalence of major depression among treated patients.

Enrollment

112 patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. age was above 19 years,
  2. patient on maintenance hemodialysis,
  3. patient had iron deficiency anemia (ferritin > 100 ng/ml)

Exclusion criteria

  1. patient has history of depression or already using antidepressant medication,
  2. Lack of ferritin level increase ≥ 50% from baseline level before IV iron administration,
  3. patient already on oral or intravenous iron supplement

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems